Toggle Mobile Navigation

Archive for the ‘Clinical’ Category

An Interview with Atul Mahableshwarkar, CNS Clinical Trial Forum Chair

Atul Mahableshwarkar, Senior Medical Director, TAKEDA PHARMACEUTICALS
Conference chair Atul Mahableshwarkar, M.D., DFAPA

CNS clinical trials are some of the most intricate, time-consuming processes modern life science professionals deal with. They necessitate a great deal of attention to detail and a strong commitment to quality from all involved parties. With ExL Events’ premiere CNS Clinical Trial Forum rapidly approaching, we spoke to conference chairperson Atul R. Mahableshwarkar, M.D., DFAPA, to learn more about him and his thoughts on this timely topic.

How did you become involved in…


A Groundbreaking Study in Latin America

DNA strandLocated in the northern hills of the Latin American country of Columbia, the secluded towns in the state of Antioquia give scientists a unique opportunity to study disease. As a result of its long-term isolation from newcomers, the intermarriage of residents has allowed genetic mutations to persist through generations. 

Because the region’s gene pool has not experienced any significant genetic mingling, it is ideal for studying bipolar and cardiovascular disease, Alzheimer’s disease, and juvenile diabetes. Unlike general population studies requiring big data collection to tease out disease…


ExL Events’ August Knowledge Management Event Makes News

ExL Events newsExL Events’ inaugural Life Science Knowledge Management Summit is in the news!

KM World recently published an article on the success of the August 2014 event and the benefits it offered to attendees. Author David Raths highlighted vital information shared at the conference, quoting Summit faculty members from Biogen Idec, Genzyme, Ironwood Pharmaceuticals, Pfizer and Merck as they addressed some of the biggest issues knowledge management professionals face today.

Read the full article over at KM World for more details about last year’s event, or visit the 


live chat software